Want Passive Income That Grows? This Is the Ultimate Stock to Buy With $1,000.

Mondelēz is facing near-term earnings pressure from elevated cocoa costs, with management saying the company may not fully benefit from lower cocoa prices until 2027 due to hedging. However, the long-term case remains supported by emerging-market growth, a $9 billion buyback authorization through December 2027, and a dividend yielding about 3.4% at roughly $59 per share. The article frames the stock as a long-duration income play, but with 2026 earnings still clouded by commodity headwinds.

Analysis

The market is treating MDLZ like a near-term margin casualty when the more durable driver is actually mix and geography: emerging-market volume growth can offset a lot of commodity noise once the hedge lag rolls off. The key second-order effect is that a temporary cocoa shock tends to force pricing, packaging, and promo discipline that can improve franchise quality; if management leans into ad spend in 2026 while competitors stay defensive, MDLZ can widen share in the categories where distribution density matters most.

The setup is less about an immediate earnings inflection and more about an earnings air pocket that creates a better entry for a compounding story. Because cocoa relief is delayed by hedging, the stock may not re-rate until investors can underwrite 2027 margin recovery plus buyback-driven EPS lift; that means the catalyst path is stretched over quarters, not days. In the meantime, the rising payout and repurchase authorization provide downside support, but only if free cash flow stays above the expected dividend/buyback burden.

Consensus appears to be over-penalizing the company for a commodity that is mean-reverting while underestimating how much of MDLZ's value creation is coming from per-share math rather than operating surprise. The real risk is not cocoa itself but a demand trade-down in emerging markets if pricing gets too aggressive or FX weakens simultaneously; that would turn a benign lag into a volume problem. On the flip side, if cocoa keeps easing into 2026, the stock could rerate well before the earnings numbers fully show it, because the market will discount the 2027 margin tailwind ahead of realization.

Key Decisions for Investors

• Initiate a staged long MDLZ position over the next 4-8 weeks on weakness, targeting a 12-18 month hold; risk/reward improves if the stock remains pinned by hedging lag while buybacks continue to reduce share count.
• Use a bullish call spread in MDLZ (6-12 month tenor) to express the 2027 margin-recovery thesis with limited carry risk; prefer strikes around current levels to avoid paying for a full normalization already in consensus.
• Pair trade: long MDLZ / short a higher-beta packaged-food peer with greater cocoa sensitivity and weaker EM exposure; the relative value should benefit as investors rotate toward companies with better per-share capital returns and geographic diversification.
• If MDLZ trades back near the January lows, add aggressively only if management commentary confirms no erosion in EM volume trends; that would offer a favorable entry where the market is pricing in a permanent earnings reset that may prove temporary.
• Avoid chasing for yield alone: the dividend is attractive, but the cleaner trade is total return via 2026-2027 EPS rebound plus repurchases, not a standalone income play.